Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna Report
Merck and Moderna released detailed results on an experimental vaccine to treat the skin cancer.
Merck and Moderna released detailed results on an experimental vaccine to treat the skin cancer. This story matters for General News readers tracking general. Reported by nytimes.com. Read the full original at the source link below.
Originally reported by nytimes.com. NewsDepot.com curates and briefs the general news stories that matter. Our editorial policy →
Get the daily general signal